Skip to content
Search

Latest Stories

Changes made to FP10 prescriptions and tokens

The reverse of all FP10 prescriptions and tokens have now been changed with an aim to help patients and pharmacy teams to easily determine the eligibility for exemption from prescription charges.

This is part of the recent introduction of new NHS prescription forms and EPS Tokens in England.


The new FP10 forms (FP10SS, FP10D, FP10PN, etc.) and tokens (FP10DT) are now in circulation and pharmacy teams are expected to see these being presented by patients in the coming weeks.

Key changes include:

  • Addition of new exemption box ‘U’ for patients who are in receipt of “Universal Credit and meets the criteria
  • Removal of box ‘X’ for “was prescribed free-of-charge contraceptives
  • Introduction of a new prescriber endorsement ‘FS’ for “free supply of sexual health treatment
  • Merging of age exemption categories (‘A’ and ‘C’) into a single category ‘A’ for “is 60 years of age or over or is under 16 years of age
  • Re-wording of exemption category ‘G’ to “Prescription exemption certificate issued by the Ministry of Defence

The Pharmaceutical Services Negotiating Committee (PSNC) reminded that pharmacists can accept both existing and new versions of FP10 forms and tokens for dispensing as the existing version will remain in circulation until their stocks are exhausted.

PSNC Drug Tariff and Reimbursement Manager, Suraj Shah, said: “Pharmacy teams regularly help patients to identify whether they are eligible for free NHS prescriptions, but this can be a time-consuming process in a busy environment. PSNC hopes that these changes – particularly the long-awaited addition of a specific exemption box for Universal Credit claimants – will help make claiming exemptions more straightforward, consequently reducing the risk of penalty charges and prescription switching.”

“Removing the requirement for patients to sign the reverse of their prescription/Token for contraceptives will also reduce the administrative burden on pharmacies, who will no longer need to submit these EPS Tokens to the NHS Business Services Authority. However, we are keen to see these changes being applied to EPS prescribing and dispensing systems as soon as possible to bring them into line with the new paper forms and Tokens,” he said.

Pharmacists are also advised to review and update their SOPs to ensure accurate completion of patient declarations on the new version of the FP10 forms and tokens.

More For You

It is official: Opella is now a standalone company

Opella launches as an independent company to redefine the future of self-care.

Photo credit: gettyimages

Opella becomes standalone company as Sanofi-CD&R deal closes

Opella has officially become a standalone company, following the completion of Sanofi’s sale of a controlling 50.0% stake to private equity firm Clayton, Dubilier & Rice (CD&R).

Sanofi retains a significant shareholding with a 48.2% stake while Bpifrance holds the remaining 1.8% stake.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less